Comparison of selective laser trabeculoplasty (SLT) in primary open angle glau

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1469-1473

  Ayala, Marcelo ^a   Chen, Enping ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Glaucoma; Inflammation; Intraocular pressure; Laser; Pseudoexfoliation

Indexed keywords

ANTIGLAUCOMA AGENT;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; INFLAMMATION; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATIENT SAFETY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PSEUDOEXFOLIATIVE GLAUCOMA; SELECTIVE LASER TRABECULOPLASTY; THERAPY EFFECT; TRABECULOPLASTY;

EID: 81155124045     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s25636     Document Type: Article

References (24)

1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.
2. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990;97(11):1403-1413.
3. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol. 1995;120(6):718-731.
4. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol. 2006;41(4):449-456.
5. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995; 60(4):359-371.
6. Karger RA, Jeng SM, Johnson DH, Hodge DO, Good MS. Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma. 2003;12(3): 193-197.
7. Aström S, Stenlund H, Lindén C. Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand. 2007;85(8):832-837.
8. Ringvold A. Epidemiology of glaucoma in northern Europe. Eur J Ophthalmol. 1996;6(1):26-29.
9. Ekström C. Prevalence of open-angle glaucoma in central Sweden. The Tierp Glaucoma Survey. Acta Ophthalmol Scand. 1996;74(2): 107-112.
10. Gracner T. Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol. 2002;12(4): 287-292.
11. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clin Ophthalmol. 2010;5:5-10.
12. Goldenfeld M, Geyer O, Segev E, Kaplan-Messas A, Melamed S. Selective Laser Trabeculoplasty in Uncontrolled Pseudoexfoliation Glaucoma. Ophthalmic Surg Lasers Imaging. 2011:1-4. doi: 10.3928/15428877-20110630-601.
13. Kanski J. Clinical Ophthalmology: A Systematic Approach. London, UK: Butterworth-Heinemann Ltd; 1990:187.
14. Chen E, Golchin S, Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma. 2004;13(1): 62-65.
15. Guex-Crosier Y, Pittet N, Herbort CP. Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment. Ophthalmology. 1995;102(4):613-621.
16. Herbort CP, Guex-Crosier Y, de Ancos E, Pittet N. Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology. 1997;104(1):64-71; discussion 71-72.
17. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology. 1998;105(11):2082-2088; discussion 2089-2090.
18. Ayala M, Landau Högbeck I, Chen E. Inflammation assessment after selective laser trabeculoplasty (SLT) treatment. Acta Ophthalmol. 2011; 89(4):e306-e309.
19. Threlkeld AB, Hertzmark E, Sturm RT, Epstein DL, Allingham RR. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma. 1996;5(5): 311-316.
20. Tuulonen A, Airaksinen PJ. Laser trabeculoplasty I in simple and capsular glaucoma. Acta Ophthalmol (Copenh). 1983;61(6):1009-1015.
21. Higginbotham EJ, Richardson TM. Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol. 1986;70(11):837-839.
22. Bergeå B. Intraocular pressure reduction after argon laser trabeculoplasty in open-angle glaucoma. A two-year follow-up. Acta Ophthalmol (Copenh). 1986;64(4):401-406.
23. Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye (Lond). 2004;18: 498-502.
24. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol. 2003;121(7): 957-960.